Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS

Clinical trial NCT00038831 · COMPLETED

Trial details

NCT number: NCT00038831
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Myelodysplastic Syndrome Chronic Lymphocytic Leukemia

Start date: 2001-05-01
Primary completion: 2005-03-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.